Publication | Closed Access

Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2–Keap1 signaling

InflammationRedox SignalingAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineImmunologyPulmonary PharmacologyPulmonary FibrosisReactive Oxygen SpecieInhibits InflammationPharmacologyCell SignalingOxidative Stress